Pediatric respiratory infections encompass a range of illnesses affecting the respiratory system in children, often caused by viruses, bacteria, or other pathogens. Common respiratory infections include viral illnesses like the common cold, influenza, respiratory syncytial virus (RSV) infections, and bacterial infections such as pneumonia and bronchitis. Respiratory infections in children are a major cause of morbidity and can lead to complications such as ear infections and exacerbations of underlying conditions like asthma. The developing immune system and close contact in daycare or school settings contribute to the increased susceptibility of children to respiratory infections. Effective management involves supportive care, antiviral or antibiotic medications when indicated, and preventive measures like vaccination against influenza and RSV. Maintaining good hygiene practices, such as handwashing and respiratory etiquette, is crucial in preventing the spread of respiratory infections among children. Research in pediatric respiratory infections focuses on understanding the epidemiology, identifying new pathogens, and developing vaccines to reduce the burden of these infections. Public health measures and parental education play essential roles in minimizing the impact of respiratory infections on pediatric health.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom